Vaccines — Types, How They Work & Recent Developments 💉
Complete UPSC Notes — made easy for everyone, including non-bio students. 6 vaccine types with visual diagrams, how the immune system learns, COVID-19 vaccine platforms (UPSC 2022!), India's vaccine story, malaria vaccine, mRNA revolution. With PYQs and MCQs.
🔥 How Do Vaccines Work? — The Simplest Explanation
💡 The "Wanted Poster" Analogy
Imagine your body is a country and your immune system is the army. When a new enemy (virus/bacteria) attacks, your army doesn't recognise it — it takes time to figure out how to fight it. During that time, you get sick. A vaccine is like giving your army a "Wanted Poster" of the enemy before it attacks. Your army studies the poster, trains special soldiers (antibodies), and memorises the enemy's face. Now, when the real enemy shows up, your army recognises it instantly and destroys it before you get sick. That's it. That's how every vaccine works.
The "Wanted Poster" is different for each vaccine type — sometimes it's a dead enemy, sometimes just a photo of the enemy's weapon, sometimes a secret instruction manual. But the goal is always the same: train the immune system before the real attack.
(antigen enters body)
(B-cells make antibodies)
(Memory T & B cells)
YOU DON'T GET SICK ✓
💉 6 Types of Vaccines — With Visual Diagrams
1. Live Attenuated Vaccines
Weakened live pathogenMimics real infection
2. Inactivated (Killed) Vaccines
Dead pathogenchemicals
Needs booster doses
3. Subunit / Recombinant / Protein Vaccines
Only a piece of the pathogenprotein only
(spike protein)
4. Viral Vector Vaccines — Asked in UPSC 2021 & 2022!
Harmless virus delivers instructions(delivery truck)
your cells
spike protein
5. mRNA Vaccines — The New Revolution
Instructions only, no virusfor spike protein
nanoparticle (LNP)
makes spike protein
mRNA degrades in hours
6. Toxoid Vaccines
Inactivated toxin🦠 COVID-19 Vaccines — Platform Comparison
| Vaccine | Platform | Developer | How It Works |
|---|---|---|---|
| Covishield | Viral Vector (NOT mRNA!) | AstraZeneca + Oxford → Serum Institute of India | Modified chimpanzee adenovirus carries spike gene |
| Sputnik V | Viral Vector | Gamaleya Institute (Russia) | Human adenovirus vectors (Ad26 + Ad5) |
| COVAXIN | Inactivated (Killed) | Bharat Biotech + ICMR (India) | Whole SARS-CoV-2 virus killed with β-propiolactone |
| Pfizer/BioNTech | mRNA | Pfizer + BioNTech (USA/Germany) | mRNA in lipid nanoparticles → cells make spike protein |
| Moderna | mRNA | Moderna (USA) | mRNA in lipid nanoparticles → cells make spike protein |
| Corbevax | Protein Subunit | Biological E (India) | Recombinant spike protein produced in yeast |
| Novavax | Protein Subunit | Novavax (USA) | Spike protein nanoparticles + Matrix-M adjuvant |
| J&J (Janssen) | Viral Vector | Johnson & Johnson (USA) | Human adenovirus (Ad26) carries spike gene |
🆕 Recent Vaccine Developments (2025–26)
🦟 India's Malaria Vaccine (2025)
ICMR licensed AdFalciVax — India's first indigenous multi-stage malaria recombinant vaccine — to 5 Indian companies (Sep 2025). Targets P. falciparum. Supports India's goal of malaria elimination by 2030.
🌍 WHO Malaria Vaccines
RTS,S/AS01 (Mosquirix) — WHO approved 2021. R21/Matrix-M — WHO approved 2023. Both target children under 5 in endemic Africa. First-ever malaria vaccines.
🧬 mRNA Beyond COVID
mRNA platform being developed for: malaria, universal flu, Nipah, cancer. India's Gennova received $13.38M from CEPI (Mar 2025) for self-amplifying mRNA (saRNA) vaccine for Nipah virus.
🦟 Dengue Vaccine
Takeda's Qdenga (dengue vaccine) aims to launch in India in 2026 via collaboration with Biological E under Make in India initiative.
🧾 UPSC PYQs on Vaccines
Answer: (b) 2 and 3 only.
Statement 1 ✗ — Covishield does NOT use mRNA. It uses viral vector platform (modified chimpanzee adenovirus ChAdOx1). Developed by AstraZeneca/Oxford, manufactured by Serum Institute of India.
Statement 2 ✓ — Sputnik V uses vector-based platform (human adenovirus Ad26 + Ad5).
Statement 3 ✓ — COVAXIN is inactivated pathogen-based (whole killed SARS-CoV-2 virus). Made by Bharat Biotech + ICMR.
Answer: (c) Both 1 and 2.
1 ✓ — Recombinant vector vaccines use genetic engineering to insert pathogen genes into harmless vectors.
2 ✓ — Both bacteria and viruses can serve as vectors. Adenovirus vectors were used in Covishield, Sputnik V, J&J. Bacterial vectors are also used in some experimental vaccines.
Answer: (d) All three correct.
I ✓ — mAbs are lab-made proteins (Hybridoma technology).
II ✓ — They bind to specific antigens → guide/enhance immune response.
III ✓ — Used against COVID-19, Ebola, and Nipah virus (m102.4 monoclonal antibody).
Note: mAbs are different from vaccines — vaccines prevent disease; mAbs treat active infections.
📝 UPSC-Style MCQs
1. mRNA vaccines contain a live virus.
2. mRNA vaccines can alter human DNA.
3. mRNA degrades within hours after producing the target protein.
Which is/are correct?
🧠 Memory Aid
🔑 Lock These In for Prelims Day
❓ FAQs
Can mRNA vaccines alter my DNA?
What is the difference between a vaccine and a monoclonal antibody?
Why does India make so many vaccines?
📜 Probable Mains Questions
"Discuss the different types of vaccine platforms. How did the COVID-19 pandemic accelerate vaccine technology innovation?"
"India is often called the 'Vaccine Capital of the World.' Discuss India's contributions to global vaccine production and the significance of schemes like BioPharma SHAKTI."
🏁 Conclusion
💉 From Smallpox to mRNA — The Vaccine Revolution
In 1796, Edward Jenner used cowpox to protect against smallpox — the world's first vaccine. Two centuries later, scientists designed a vaccine against COVID-19 in just 2 days (Moderna's mRNA sequence was finalised on January 13, 2020, just two days after China shared the virus's genetic sequence). Between these two moments lies the entire arc of vaccine science: from live attenuated to inactivated, from subunit to viral vector, from protein to mRNA.
For UPSC, the COVID-19 pandemic turned vaccine technology into a high-frequency exam topic. The 2021 question tested recombinant vector vaccines. The 2022 question tested COVID vaccine platforms (and trapped candidates who confused Covishield with mRNA). The 2025 question tested monoclonal antibodies. The pattern is clear: know the platforms, know the Indian examples, know the differences.
The one line to remember: Covishield = VIRAL VECTOR (not mRNA). COVAXIN = INACTIVATED. Pfizer/Moderna = mRNA. Sputnik V = VIRAL VECTOR. Corbevax = PROTEIN SUBUNIT. This single table has been worth 2 marks in UPSC Prelims.


